NCT02024529View on ClinicalTrials.gov

A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee

PHASE3CompletedINTERVENTIONAL
Enrollment

538

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2014

Conditions
Osteoarthritis of the Knee
Interventions
BIOLOGICAL

4 mL injection of Ampion

4 mL injection of Ampion

DRUG

4 mL Injection of Placebo

4 mL Injection of Placebo

Sponsors
All Listed Sponsors
lead

Ampio Pharmaceuticals. Inc.

INDUSTRY

NCT02024529 - A Randomized, Controlled Study to Evaluate Efficacy and Safety of Intra-articular Ampion for Osteoarthritis Pain in Knee | Biotech Hunter | Biotech Hunter